Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: a pilot study
The low dose application of chemotherapeutic agents such as paclitaxel was previously shown to initiate anti-tumor activity by neutralizing myeloid-derived suppressor cells (MDSCs) in melanoma mouse models. Here, we investigated immunomodulating effects of low-dose paclitaxel in 9 metastatic melanom...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2021
|
| In: |
Cellular immunology
Year: 2021, Volume: 360, Pages: 1-9 |
| ISSN: | 1090-2163 |
| DOI: | 10.1016/j.cellimm.2020.104274 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cellimm.2020.104274 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0008874920304342 |
| Author Notes: | Christoffer Gebhardt, Sonja C.S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1751134792 | ||
| 003 | DE-627 | ||
| 005 | 20230427005710.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210311s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cellimm.2020.104274 |2 doi | |
| 035 | |a (DE-627)1751134792 | ||
| 035 | |a (DE-599)KXP1751134792 | ||
| 035 | |a (OCoLC)1341398454 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gebhardt, Christoffer |d 1976- |e VerfasserIn |0 (DE-588)13051151X |0 (DE-627)503031666 |0 (DE-576)298240289 |4 aut | |
| 245 | 1 | 0 | |a Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade |b a pilot study |c Christoffer Gebhardt, Sonja C.S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal |
| 264 | 1 | |c 2021 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 28 December 2020 | ||
| 500 | |a Gesehen am 30.11.2021 | ||
| 520 | |a The low dose application of chemotherapeutic agents such as paclitaxel was previously shown to initiate anti-tumor activity by neutralizing myeloid-derived suppressor cells (MDSCs) in melanoma mouse models. Here, we investigated immunomodulating effects of low-dose paclitaxel in 9 metastatic melanoma patients resistant to prior treatments. Three patients showed response to therapy (two partial responses and one stable disease). In responding patients, paclitaxel decreased the frequency and immunosuppressive pattern of MDSCs in the peripheral blood and skin metastases. Furthermore, paclitaxel modulated levels of inflammatory mediators in the serum. In addition, responders displayed enhanced frequencies of tumor-infiltrating CD8+ T cells and their activity indicated by the upregulation of CD25 and TCR ζ-chain expression. Our study suggests that low-dose paclitaxel treatment could improve clinical outcome of some advanced melanoma patients by enhancing anti-tumor immunity and might be proposed for combined melanoma immunotherapy. | ||
| 650 | 4 | |a Immune checkpoint blockade | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Melanoma | |
| 650 | 4 | |a Myeloid suppressor cells | |
| 650 | 4 | |a Paclitaxel | |
| 700 | 1 | |a Simon, Sonja C. S. |d 1990- |e VerfasserIn |0 (DE-588)1208016903 |0 (DE-627)1694314316 |4 aut | |
| 700 | 1 | |a Bitsch, Rebekka |d 1991- |e VerfasserIn |0 (DE-588)1163544582 |0 (DE-627)1027872069 |0 (DE-576)508043565 |4 aut | |
| 700 | 1 | |a Gries, Mirko |d 1985- |e VerfasserIn |0 (DE-588)1229655727 |0 (DE-627)1751726452 |4 aut | |
| 700 | 1 | |a Mun, Dong Hun |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reinhard, Raphael |d 1988- |e VerfasserIn |0 (DE-588)112275499X |0 (DE-627)87613326X |0 (DE-576)481470344 |4 aut | |
| 700 | 1 | |a Holland-Letz, Tim |e VerfasserIn |0 (DE-588)142336491 |0 (DE-627)658880470 |0 (DE-576)343311291 |4 aut | |
| 700 | 1 | |a Umansky, Viktor |d 1955- |e VerfasserIn |0 (DE-588)102885756X |0 (DE-627)731733207 |0 (DE-576)376300078 |4 aut | |
| 700 | 1 | |a Utikal, Jochen |d 1974- |e VerfasserIn |0 (DE-588)1026463750 |0 (DE-627)726765015 |0 (DE-576)371816580 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cellular immunology |d Orlando, Fla. : Academic Press, 1970 |g 360(2021), Artikel-ID 104274, Seite 1-9 |h Online-Ressource |w (DE-627)254635059 |w (DE-600)1462601-9 |w (DE-576)104193646 |x 1090-2163 |7 nnas |a Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade a pilot study |
| 773 | 1 | 8 | |g volume:360 |g year:2021 |g elocationid:104274 |g pages:1-9 |g extent:9 |a Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade a pilot study |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.cellimm.2020.104274 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0008874920304342 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210311 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1026463750 |a Utikal, Jochen |m 1026463750:Utikal, Jochen |d 60000 |e 60000PU1026463750 |k 0/60000/ |p 9 |y j | ||
| 998 | |g 102885756X |a Umansky, Viktor |m 102885756X:Umansky, Viktor |d 140000 |d 60000 |d 61900 |e 140000PU102885756X |e 60000PU102885756X |e 61900PU102885756X |k 0/140000/ |k 0/60000/ |k 1/60000/61900/ |p 8 | ||
| 998 | |g 142336491 |a Holland-Letz, Tim |m 142336491:Holland-Letz, Tim |d 50000 |e 50000PH142336491 |k 0/50000/ |p 7 | ||
| 998 | |g 112275499X |a Reinhard, Raphael |m 112275499X:Reinhard, Raphael |d 60000 |d 61900 |e 60000PR112275499X |e 61900PR112275499X |k 0/60000/ |k 1/60000/61900/ |p 6 | ||
| 998 | |g 1229655727 |a Gries, Mirko |m 1229655727:Gries, Mirko |d 60000 |e 60000PG1229655727 |k 0/60000/ |p 4 | ||
| 998 | |g 1163544582 |a Bitsch, Rebekka |m 1163544582:Bitsch, Rebekka |d 60000 |d 61900 |e 60000PB1163544582 |e 61900PB1163544582 |k 0/60000/ |k 1/60000/61900/ |p 3 | ||
| 998 | |g 1208016903 |a Simon, Sonja C. S. |m 1208016903:Simon, Sonja C. S. |d 60000 |d 61900 |e 60000PS1208016903 |e 61900PS1208016903 |k 0/60000/ |k 1/60000/61900/ |p 2 | ||
| 998 | |g 13051151X |a Gebhardt, Christoffer |m 13051151X:Gebhardt, Christoffer |p 1 |x j | ||
| 999 | |a KXP-PPN1751134792 |e 3884782991 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Available online 28 December 2020","Gesehen am 30.11.2021"],"id":{"doi":["10.1016/j.cellimm.2020.104274"],"eki":["1751134792"]},"title":[{"subtitle":"a pilot study","title":"Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade","title_sort":"Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade"}],"recId":"1751134792","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021"}],"relHost":[{"recId":"254635059","pubHistory":["1.1970 -"],"origin":[{"publisher":"Academic Press ; Elsevier","dateIssuedKey":"1970","publisherPlace":"Orlando, Fla. ; Amsterdam [u.a.]","dateIssuedDisp":"1970-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"9","year":"2021","pages":"1-9","text":"360(2021), Artikel-ID 104274, Seite 1-9","volume":"360"},"note":["Gesehen am 22.01.2020"],"disp":"Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade a pilot studyCellular immunology","title":[{"title":"Cellular immunology","title_sort":"Cellular immunology"}],"id":{"issn":["1090-2163"],"eki":["254635059"],"zdb":["1462601-9"]}}],"person":[{"roleDisplay":"VerfasserIn","family":"Gebhardt","role":"aut","display":"Gebhardt, Christoffer","given":"Christoffer"},{"family":"Simon","roleDisplay":"VerfasserIn","given":"Sonja C. S.","role":"aut","display":"Simon, Sonja C. S."},{"given":"Rebekka","role":"aut","display":"Bitsch, Rebekka","family":"Bitsch","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Gries","display":"Gries, Mirko","role":"aut","given":"Mirko"},{"role":"aut","display":"Mun, Dong Hun","given":"Dong Hun","roleDisplay":"VerfasserIn","family":"Mun"},{"roleDisplay":"VerfasserIn","family":"Reinhard","role":"aut","display":"Reinhard, Raphael","given":"Raphael"},{"role":"aut","display":"Holland-Letz, Tim","given":"Tim","family":"Holland-Letz","roleDisplay":"VerfasserIn"},{"family":"Umansky","roleDisplay":"VerfasserIn","role":"aut","display":"Umansky, Viktor","given":"Viktor"},{"display":"Utikal, Jochen","role":"aut","given":"Jochen","roleDisplay":"VerfasserIn","family":"Utikal"}],"name":{"displayForm":["Christoffer Gebhardt, Sonja C.S. Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal"]},"physDesc":[{"extent":"9 S."}]} | ||
| SRT | |a GEBHARDTCHPOTENTIALT2021 | ||